Pages that link to "Q36903274"
Jump to navigation
Jump to search
The following pages link to Role of metalloproteinases in platelet function. (Q36903274):
Displaying 50 items.
- A secreted tyrosine kinase acts in the extracellular environment (Q24303065) (← links)
- The signaling role of CD40 ligand in platelet biology and in platelet component transfusion (Q26863134) (← links)
- Emerging roles for platelets as immune and inflammatory cells (Q27016553) (← links)
- Role of platelets in neuroinflammation: a wide-angle perspective (Q28393808) (← links)
- Elucidation of flow-mediated tumour cell-induced platelet aggregation using an ultrasound standing wave trap. (Q30468939) (← links)
- Metalloproteinase regulation improves in vitro generation of efficacious platelets from mouse embryonic stem cells (Q30483213) (← links)
- Blood platelets and inflammation: Their relationship with liver and digestive diseases (Q33394857) (← links)
- Platelets and cancer: a casual or causal relationship: revisited. (Q34294719) (← links)
- Plasmodium coatneyi in rhesus macaques replicates the multisystemic dysfunction of severe malaria in humans (Q34333912) (← links)
- TAILS N-terminomics of human platelets reveals pervasive metalloproteinase-dependent proteolytic processing in storage (Q34737567) (← links)
- Association of sepsis-related mortality with early increase of TIMP-1/MMP-9 ratio. (Q35146507) (← links)
- Increased expression of angiogenic and inflammatory proteins in the vitreous of patients with ischemic central retinal vein occlusion (Q35610722) (← links)
- Inhibition of MCF-7 breast cancer cell-induced platelet aggregation using a combination of antiplatelet drugs (Q36611493) (← links)
- The 372 T/C genetic polymorphism of TIMP-1 is associated with serum levels of TIMP-1 and survival in patients with severe sepsis. (Q36997866) (← links)
- The role of platelet activation in tumor metastasis. (Q37242670) (← links)
- Tissue inhibitor of metalloproteinases-4. The road less traveled. (Q37331834) (← links)
- Translating molecular medicine into clinical tools: doomed to fail by neglecting basic preanalytical principles (Q37396665) (← links)
- Loss of matrix metalloproteinase 2 in platelets reduces arterial thrombosis in vivo. (Q37402384) (← links)
- Matrix metalloproteinase-9, -10, and tissue inhibitor of matrix metalloproteinases-1 blood levels as biomarkers of severity and mortality in sepsis. (Q37443132) (← links)
- Matrix metalloproteinases and peripheral arterial disease (Q37559372) (← links)
- Matrix metalloproteinase-2 and myocardial oxidative stress injury: beyond the matrix (Q37573155) (← links)
- Tissue inhibitor of metalloproteinases (TIMPs) in heart failure (Q37895982) (← links)
- Interactions between the extracellular matrix and inflammation during viral myocarditis (Q37930119) (← links)
- Platelet-associated angiogenesis regulating factors: a pharmacological perspective (Q38003425) (← links)
- Can platelet-rich plasma (PRP) improve bone healing? A comparison between the theory and experimental outcomes. (Q38063806) (← links)
- A platelet-inspired paradigm for nanomedicine targeted to multiple diseases (Q38145567) (← links)
- Host matrix metalloproteinases in cerebral malaria: new kids on the block against blood-brain barrier integrity? (Q38182192) (← links)
- Metalloproteinases in hypertension and cardiac disease: differential expression and mutual regulation (Q38224470) (← links)
- Platelet-targeted pharmacologic treatments as anti-cancer therapy (Q38657846) (← links)
- Thrombin-unique coagulation system protein with multifaceted impacts on cancer and metastasis. (Q38836736) (← links)
- CD154 is released from T-cells by a disintegrin and metalloproteinase domain-containing protein 10 (ADAM10) and ADAM17 in a CD40 protein-dependent manner (Q39067245) (← links)
- On the origin of matrix metalloproteinase-2 and -9 in blood platelets (Q39339846) (← links)
- Pharmacological characterization of nanoparticle-induced platelet microaggregation using quartz crystal microbalance with dissipation: comparison with light aggregometry (Q40597413) (← links)
- MMP-2, MMP-9, and TIMP-4 and Response to Aspirin in Diabetic and Nondiabetic Patients with Stable Coronary Artery Disease: A Pilot Study. (Q41099760) (← links)
- Extensive Characterization of Platelet Gel Releasate From Cord Blood in Regenerative Medicine. (Q41392928) (← links)
- Effects of oxidative stress on amyloid precursor protein processing in rat and human platelets (Q42166961) (← links)
- Is serum matrix metalloproteinase 9 a useful biomarker in detection of colorectal cancer? Considering pre-analytical interference that may influence diagnostic accuracy (Q42424812) (← links)
- Preliminary evidence for a matrix metalloproteinase-2 (MMP-2)-dependent shedding of soluble CD40 ligand (sCD40L) from activated platelets (Q43265578) (← links)
- Platelet shedding of CD40L is regulated by matrix metalloproteinase-9 in abdominal sepsis (Q43468988) (← links)
- Platelet compatibility of PLGA, chitosan and PLGA-chitosan nanoparticles (Q44765785) (← links)
- Inhibitory mechanisms of dihydroginsenoside Rg3 in platelet aggregation: critical roles of ERK2 and cAMP. (Q46289411) (← links)
- Transcriptomic profiling of platelet senescence and platelet extracellular vesicles. (Q46439891) (← links)
- Diabetes may affect the expression of matrix metalloproteinases and their inhibitors more than smoking in chronic periodontitis (Q47866957) (← links)
- Considerations on inhibition approaches for proinflammatory functions of ADAM proteases. (Q50495797) (← links)
- The role of serum levels of microRNA-21 and matrix metalloproteinase-9 in patients with acute coronary syndrome (Q51535970) (← links)
- Matrix metalloproteinase 2 attenuates brain tumour growth, while promoting macrophage recruitment and vascular repair. (Q55463274) (← links)
- Phenotypic heterogeneity in the Gray platelet syndrome extends to the expression of TREM family member, TLT-1. (Q55667972) (← links)
- Trends in matrix metalloproteinase research from 1986–2007: a bibliometric study (Q57214751) (← links)
- Comparison of the perioperative time courses of matrix metalloproteinase-9 (MMP-9) and its inhibitor (TIMP-1) during carotid artery stenting (CAS) and carotid endarterectomy (CEA) (Q58695988) (← links)
- Effect of tumor microenvironment on pathogenesis of the head and neck squamous cell carcinoma: a systematic review (Q64100339) (← links)